Database Registry of the Intermountain Heart Collaborative Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

30000 participants

Study Classification

OBSERVATIONAL

Study Start Date

1994-10-31

Study Completion Date

2027-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the registry is to collect and analyze clinical and laboratory data and tissue samples from patients who are diagnosed with any type of heart disease and to collect the same information and samples from healthy controls in participating Intermountain Healthcare facilities.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Assessing Changes in Myocardial Tissue and Blood in Patients With Advanced Heart Disease

NCT01099982

Congestive Heart Failure

RECRUITING

Immunogenetic Factors of Coronary Heart Disease

NCT00005184

Cardiovascular Diseases Coronary Disease Heart Diseases +4 more

COMPLETED

Belgian Registry on Coronary Function Testing

NCT06089031

Coronary Microvascular Dysfunction Coronary Artery Vasospasm

RECRUITING

Recovery of Hibernating Myocardium in End Stage Heart Failure

NCT02573207

Myocardial Function After LVAD Implant Ischemic Cardiomyopathy

TERMINATED

The Multicenter Cardiology Monitoring Platform Registry

NCT04976348

Heart Failure Cardiomyopathies Atrial Fibrillation +3 more

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a registry (database) project; there are no investigational treatments, drug or procedures associated with participation in registry activities. This project is an organized data gathering and storing (database) endeavor with specific focus on the precursors, modifiers, biological, and genetic parameters of heart disease and related medical conditions. Data collection will not immediately influence the course of treatment for any patient.Sample testing and data utilization for basic science, clinical, and epidemiologic and publication projects can be initiated using the databank.

The registry will enable researchers to determine best medical practices for predicting, preventing, and treating heart disease. The registry will: 1) develop standard methods to collect data and specimens which will be used for research to characterize patients diagnosed with heart disease as well as healthy controls and to assess differences in demographics and patient outcomes in both populations; 2) collect, process, and store patients' clinical data and tissue/blood samples; 3) analyze data collected; 4) use these resources to identify genes, genetic polymorphisms, genetic mutations, clinical methods and procedures, and/or biomarkers that predict, prevent, or treat heart disease and/or are associated correlate with lifestyle or disease outcomes; 5) publish and disseminate results.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Disease Electrophysiology Cardiovascular Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. The patient (male or non-pregnant female) must be \> 18 years of age.
2. The patient or legally authorized representative must sign a written informed consent, prior to the procedure, using a form that is approved by the local Institutional Review Board.

Exclusion Criteria

1. Neither patient nor patient representative understands spoken English.
2. Neither patient nor the patient's personal representative is willing to give written consent for participation.
3. Healthy control patients must sign their own consent document.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes